This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Ipsen Bioinnovation Limited, Merz Pharma Gmbh & Co Kgaa, Syntaxin Limited. Active years: 2008-2021.
Company Filing History:
3 out of 27 
2 out of 107 
2 out of 36 
Years Active: 2008-2021
Title: The Innovative Mind of Aleksandrs Gutcaits
Introduction
Aleksandrs Gutcaits is a notable inventor based in Riga, Latvia. With a total of 8 patents to his name, he has made significant contributions to the field of biotechnology, particularly in the development of targeted transport proteins.
Latest Patents
One of Gutcaits' latest inventions is a Carrier for targeting nerve cells. This innovation focuses on a transport protein that is created by modifying the heavy chain of a neurotoxin. Key features of this invention include the protein's ability to bind specifically to nerve cells with varying affinity compared to the native neurotoxin, its altered neurotoxicity as ascertained through the hemidiaphragm assay, and a reduced affinity against neutralizing antibodies. This versatile protein holds promise for applications in both cosmetic and pharmaceutical compositions.
Career Highlights
Aleksandrs Gutcaits has worked with prominent organizations such as Ipsen Bioinnovation Limited and Syntaxin Limited. His role in these companies has been pivotal in advancing research and development in the field of innovative medicinal therapies.
Collaborations
Throughout his career, Gutcaits has collaborated with esteemed professionals in the industry, including Tanja Weil and Andreas Rummel. These partnerships have enriched his work and ensured the successful development of his groundbreaking inventions.
Conclusion
Aleksandrs Gutcaits continues to push the boundaries of biotechnology through his innovative research and patents. His contributions not only pave the way for advancements in medical science but also demonstrate the vital role that inventors play in shaping the future of health and medicine.